Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1184 |
Rivaroxaban
BAY 59-7939,利伐沙班 |
Factor Xa; Thrombin | Metabolism; Proteases/Proteasome |
Rivaroxaban (BAY 59-7939) 是高效选择性的凝血因子 Xa (FXa) 直接抑制剂,IC50=0.7 nM,Ki 为 0.4 nM。 | |||
T67853 |
Rivaroxaban Impurity
Rivaroxaban-10 |
Factor Xa | Metabolism |
Rivaroxaban Impurity (Rivaroxaban-10) 是一种强效凝血因子Xa 抑制剂,IC50=66 nM。 | |||
T10174 |
5-R-Rivaroxaban
|
Factor Xa | Metabolism |
5-R-Rivaroxaban 是一种 Rivaroxaban 的 R 型对映体。其中 Rivaroxaban 是选择性的Factor Xa(FXa) 抑制剂。 | |||
T78215 |
Dechloro Rivaroxaban
|
Factor Xa; Others | Metabolism; Others |
Dechloro Rivaroxaban 是一种具有口服活性和高选择性的 Factor Xa 抑制剂。Dechloro Rivaroxaban 对人体内游离 FXa 的抑制作用显著。Dechloro Rivaroxaban 对凝血酶原以及纤维蛋白相关的 FXa 活性也有抑制效果。 | |||
T12736 |
Rivaroxaban-d4
BAY 59-7939 D4 |
Factor Xa | Metabolism |
Rivaroxaban D4 is a deuterium labeled Rivaroxaban. Rivaroxaban is a highly potent,selective and direct inhibitor of Factor Xa (FXa)(IC50:0.7 nM; Ki:0.4 nM). | |||
T71096 |
GCC-4401C methanesulfonate
|
||
GCC-4401C methanesulfonate is a factor Xa inhibitor similar to rivaroxaban that is currently under development for venous thromboembolic disease (VTE). | |||
T71362 |
GCC-4401C free base
|
||
GCC-4401C free base is a factor Xa inhibitor similar to rivaroxaban that is currently under development for venous thromboembolic disease (VTE). |